The physiological mechanisms underlying severe burns are not well understood. Researchers used mass spectrometry to identify key blood proteins associated with burn mortality. Ultimately, three ...
Danish company Novo Nordisk have announced positive results from the ONWARDS 5 phase 3 trial, with once-weekly insulin icodec demonstrating superior reduction of HbA1 in people with type 2 diabetes, ...
Researchers led by Osaka University have used mass spectrometry to identify ten blood proteins associated with mortality in severe burns. Three of these proteins (HBA1, TTR, SERPINF2) may serve as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results